Viewing Study NCT01792518


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-02-21 @ 2:51 PM
Study NCT ID: NCT01792518
Status: COMPLETED
Last Update Posted: 2017-03-06
First Post: 2013-02-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02
Start Date Type: None
Primary Completion Date: 2015-11
Primary Completion Date Type: ACTUAL
Completion Date: 2015-12
Completion Date Type: ACTUAL
First Submit Date: 2013-02-14
First Submit QC Date: None
Study First Post Date: 2013-02-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-11-08
Results First Submit QC Date: None
Results First Post Date: 2017-03-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-01-13
Last Update Post Date: 2017-03-06
Last Update Post Date Type: ACTUAL